• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 05/01/15

    • 30-Day SEC Yield1

      1.72%
    • Total Net Assets

      $367.5M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.42%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      06/30/2015
  • Portfolio Composition (%)
    as of 05/01/15

    • % of Net Assets
    • Stocks

      100.09
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.09
  • Download All HoldingsAll Holdings (%) as of 05/01/15

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Novartis Ag
    NVS US
    339,870
    35,125,5659.56
    Johnson & Johnson
    JNJ US
    305,098
    30,549,4638.31
    Pfizer Inc
    PFE US
    713,014
    24,299,5176.61
    Novo Nordisk A/S
    NVO US
    376,759
    21,535,5445.86
    Sanofi
    SNY US
    369,370
    18,944,9875.16
    Merck & Co Inc
    MRK US
    309,209
    18,509,2515.04
    Valeant Pharmaceuticals International I
    VRX US
    80,539
    17,961,8084.89
    Abbvie Inc
    ABBV US
    275,537
    17,722,5404.82
    Glaxosmithkline Plc
    GSK US
    379,889
    17,463,4974.75
    Actavis Plc
    ACT US
    59,188
    17,149,1314.67
    Eli Lilly & Co
    LLY US
    227,891
    16,663,3904.53
    Astrazeneca Plc
    AZN US
    242,097
    16,433,5444.47
    Abbott Laboratories
    ABT US
    336,957
    15,732,5224.28
    Bristol-Myers Squibb Co
    BMY US
    237,814
    15,377,0534.18
    Teva Pharmaceutical Industries Ltd
    TEVA US
    244,047
    15,172,4024.13
    Shire Plc
    SHPG US
    59,070
    14,407,1733.92
    Mckesson Corp
    MCK US
    58,658
    13,194,5313.59
    Mylan Inc/Pa
    MYL US
    123,046
    9,091,8692.47
    Perrigo Co
    PRGO US
    42,277
    7,874,5142.14
    Amerisourcebergen Corp
    ABC US
    61,394
    7,036,3661.91
    Zoetis Inc
    ZTS US
    126,159
    5,627,9531.53
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    40,435
    3,438,9970.94
    Mallinckrodt Plc
    MNK US
    28,940
    3,304,9480.90
    Hospira Inc
    HSP US
    33,656
    2,937,8320.80
    Jazz Pharmaceuticals Plc
    JAZZ US
    12,642
    2,284,9150.62
    Other/Cash
    -332,922-0.09
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.